Endocannabinoid System and Alcohol Abuse Disorders.


Journal

Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103

Informations de publication

Date de publication:
2019
Historique:
entrez: 24 7 2019
pubmed: 25 7 2019
medline: 12 9 2019
Statut: ppublish

Résumé

Δ

Identifiants

pubmed: 31332736
doi: 10.1007/978-3-030-21737-2_6
doi:

Substances chimiques

Endocannabinoids 0
Receptor, Cannabinoid, CB1 0
Ethanol 3K9958V90M

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

89-127

Subventions

Organisme : NIAAA NIH HHS
ID : R01 AA019443
Pays : United States

Auteurs

Balapal S Basavarajappa (BS)

Division of Analytical Psychopharmacology, New York State Psychiatric Institute, New York, NY, USA. Basavaraj.Balapal@nki.rfmh.org.
Department of Psychiatry, College of Physicians & Surgeons, Columbia University, New York, NY, USA. Basavaraj.Balapal@nki.rfmh.org.
Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USA. Basavaraj.Balapal@nki.rfmh.org.
Department of Psychiatry, New York University Langone Medical Center, New York, NY, USA. Basavaraj.Balapal@nki.rfmh.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH